Renal Cell Carcinoma Studies – Using health economics services to add sustainable value
Add bookmark
The collection of late phase clinical oncology trial data has seen an increasing emphasis placed on the collection of economic figures following a compound being brought to market. As the competition for new compounds and devices continue to escalate in parallel to the costs of running effective trials, particularly in the high-cost oncology trial market, a contract research organisation that has the scale and expertise to map out economic considerations, early and inexpensively, provides an att...
